Eterna Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Eterna Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Eterna Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 51.4M shares, a 850% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 51.4M +46M +850% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 5.41M +257 +0.01% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 5.41M +283K +5.53% Mar 12, 2024 10-K/A 2024-03-18
Q3 2023 5.41M +2.47M +83.9% Nov 10, 2023 10-Q 2023-11-13
Q2 2023 5.41M -52.1M -90.6% Aug 8, 2023 10-Q 2023-08-11
Q1 2023 5.13M -52.3M -91.1% Mar 20, 2023 10-K 2023-03-20
Q3 2022 2.94M -49.1M -94.3% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 57.5M +5.74M +11.1% Jun 30, 2022 10-Q 2022-07-01
Q1 2022 57.5M +54.5M +1830% Apr 12, 2022 10-K/A 2022-07-01
Q3 2021 52M +49.1M +1657% Nov 8, 2021 10-Q 2021-11-12
Q2 2021 51.7M +48.8M +1654% Aug 12, 2021 10-Q 2021-08-13
Q1 2021 2.98M +62K +2.13% Mar 9, 2021 10-K 2021-03-11
Q3 2020 2.96M +64K +2.21% Nov 10, 2020 10-Q 2020-11-13
Q2 2020 2.95M +65.1K +2.26% Aug 5, 2020 10-Q 2020-08-10
Q1 2020 2.91M +37.6K +1.31% Mar 16, 2020 10-K 2020-03-19
Q3 2019 2.9M +25.5K +0.89% Oct 30, 2019 10-Q 2019-11-01
Q2 2019 2.88M +17.4K +0.61% Aug 7, 2019 10-Q 2019-08-12
Q1 2019 2.88M +357K +14.1% Mar 20, 2019 10-K 2019-03-22
Q3 2018 2.87M +353K +14% Nov 7, 2018 10-Q 2018-11-09
Q2 2018 2.87M +351K +13.9% Aug 2, 2018 10-Q 2018-08-06
Q1 2018 2.52M +260K +11.5% Mar 6, 2018 10-K 2018-03-09
Q3 2017 2.52M +260K +11.5% Nov 6, 2017 10-Q 2017-11-08
Q2 2017 2.52M +667K +36.1% Aug 2, 2017 10-Q 2017-08-04
Q1 2017 2.26M -90.2M -97.6% Mar 7, 2017 10-K 2017-03-09
Q3 2016 2.26M -90.2M -97.6% Nov 8, 2016 10-Q 2016-11-09
Q2 2016 1.85M -90.6M -98% Aug 2, 2016 10-Q 2016-08-04
Q1 2016 92.4M +58.2K +0.06% Mar 4, 2016 10-K 2016-03-15
Q3 2015 92.4M +115K +0.13% Nov 5, 2015 10-Q 2015-11-09
Q2 2015 92.4M +690K +0.75% Aug 7, 2015 10-Q 2015-08-10
Q1 2015 92.4M +13.7M +17.4% Mar 24, 2015 10-K 2015-03-27
Q3 2014 92.3M +20.5M +28.6% Nov 5, 2014 10-Q 2014-11-07
Q2 2014 91.7M +20M +27.9% Aug 11, 2014 10-Q 2014-08-14
Q1 2014 78.7M +7.21M +10.1% Mar 26, 2014 10-K 2014-03-31
Q3 2013 71.8M +710K +1% Nov 11, 2013 10-Q 2013-11-14
Q2 2013 71.7M +678K +0.96% Aug 14, 2013 10-Q 2013-08-14
Q1 2013 71.5M +518K +0.73% Mar 26, 2013 10-K 2013-03-29
Q3 2012 71.1M +10.2M +16.7% Nov 5, 2012 10-Q 2012-11-09
Q2 2012 71M +10.2M +16.7% Aug 7, 2012 10-Q 2012-08-14
Q1 2012 71M Mar 26, 2012 10-K 2012-03-30
Q3 2011 60.9M Nov 5, 2011 10-Q 2011-11-14
Q2 2011 60.9M Aug 5, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.